Skip to main content
. 2004 Nov;48(11):4444–4446. doi: 10.1128/AAC.48.11.4444-4446.2004

TABLE 1.

Susceptibility of 296 invasive GBS isolates to different antibiotics

Antibiotic MIC (μg/ml)
Breakpointsa (μg/ml) % (no./total) Resistant
Range 50% of isolates 90% of isolates
Penicillin G 0.016-0.125 0.047 0.064 <0.12 0
Ampicillin 0.016-0.125 0.094 0.094 <0.25 0
Cefotaxime 0.023-0.19 0.047 0.064 <0.5 0
Erythromycin 0.023->256 0.094 0.94 0.25 10.1 (30/296)
Clindamycin 0.038->256 0.19 0.25 <0.25 5.7 (17/296)
Gentamicin 32-256 128 128 <1.0 100
Linezolid 0.25-1.5 1.0 1.5 >4c 0
Q-Db 0.19-1.5 0.50 0.75 <1.0 0
Imipenem 0.004-0.19 0.032 0.064 <0.5 0
Meropenem 0.012-0.094 0.032 0.047 <0.5 0
Ertapenem 0.023-0.094 0.047 0.064 <1.0 0
Vancomycin 0.38-1.0 1.0 1.0 <1.0 0
a

If not indicated otherwise, NCCLS (19) breakpoints were used. For linezolid and gentamicin, European Committee on Antimicrobial Susceptibility Testing (10) and Deutsche Industrie Norm (9) breakpoints were used, respectively.

b

Q-D, quinupristin-dalfopristin.

c

Resistant.